BCR and non-Hodgkin lymphoma: Patients with ALL achieved 73% BCR (95%CI:60–83%, I2: 77%), 57% OS (95%CI:45–68%%, I2: 67%), and 80% BOR (95%CI:66–89%, I2: 64%) %) (Suppl Figs. 34, 35 and 36, respectively), while for NHL, the general BCR was 51% (95%CI:45–57%, I2: 75%), 59% OS (95%CI:46–72%, I2: 92%) and 71% BOR (95%CI:63–78%, I2: 74%) (Suppl Figs. 34, 35 and 36, respectively).